<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JBM</journal-id><journal-title-group><journal-title>Journal of Biosciences and Medicines</journal-title></journal-title-group><issn pub-type="epub">2327-5081</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jbm.2023.117012</article-id><article-id pub-id-type="publisher-id">JBM-126424</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Physical Activity Alters Superoxide Dismutase Activity and Intercellular Adhesion Molecule 1 Levels in Diabetes Mellitus Type 2 Patients
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Anderson</surname><given-names>Martins Tavares</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Leonardo</surname><given-names>Matta</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jaslana</surname><given-names>Hainfellner da Silva</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Christiane</surname><given-names>de Oliveira Bensusan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Carla</surname><given-names>do Nascimento</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Giselle</surname><given-names>Fernandes Taboada</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Rodrigo</surname><given-names>Soares Fortunato</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Luciene</surname><given-names>de Carvalho Cardoso-Weide</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff4"><addr-line>Endocrinology Unit, Department of Internal Medicine, School of Medicine, UFF-Universidade Federal Fluminense, Rio de Janeiro, Brazil</addr-line></aff><aff id="aff1"><addr-line>Postgraduate Program in Medical Sciences, School of Medicine, UFF-Universidade Federal Fluminense, Rio de Janeiro, Brazil</addr-line></aff><aff id="aff3"><addr-line>School of Biology, University Salgado de Oliveira, Rio de Janeiro, Brazil</addr-line></aff><aff id="aff5"><addr-line>Medical School, Department of Pathology, UFF-Universidade Federal Fluminense, Rio de Janeiro, Brazil</addr-line></aff><aff id="aff2"><addr-line>Carlos Chagas Filho Institute of Biophysics, UFRJ-Federal University of Rio de Janeiro, Rio de Janeiro, Brazil</addr-line></aff><pub-date pub-type="epub"><day>06</day><month>07</month><year>2023</year></pub-date><volume>11</volume><issue>07</issue><fpage>140</fpage><lpage>150</lpage><history><date date-type="received"><day>16,</day>	<month>June</month>	<year>2023</year></date><date date-type="rev-recd"><day>17,</day>	<month>July</month>	<year>2023</year>	</date><date date-type="accepted"><day>20,</day>	<month>July</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Oxidative stress and inflammation are related to the pathophysiology of diabetes mellitus (DM), being involved in the development of micro-and macrovascular complications. Physical activity is beneficial for DM patients, but little is known about the relationship between redox and inflammation biomarkers and the level of physical activity in these patients. Based on this, this research aims to evaluate the effects of physical activity level on redox stress parameters and inflammatory markers in T2DM patients. 
  Methods: Eighty-four patients with T2DM were divided according to their physical activity level: group A (n = 48), sedentary; group B (n = 11) active (3 times a week, 150 min) and group C (n = 25), highly active (5 times a week, 150 - 300 mins, at least). Anthropometric and biochemical parameters, superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities, as well as GSH, sRAGE and ICAM-1 levels were assessed. 
  Results: Glycated haemoglobin, total cholesterol, and LDL-cholesterol levels were lower in the highly active group in comparison to other groups. Plasma SOD activity was higher in group C compared to Group A, while ICAM-1 levels were significantly higher in group B when compared to other groups. 
  Conclusion: Our results suggest that the practice of physical activity is beneficial to T2DM patients, especially at high volume and frequency.
 
</p></abstract><kwd-group><kwd>Cardiovascular Risk</kwd><kwd> Exercise</kwd><kwd> Health</kwd><kwd> Inflammation</kwd><kwd> Oxidative Stress</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Diabetes mellitus (DM) is considered a public health issue with increasing incidence and prevalence worldwide. DM is a group of metabolic diseases characterised by chronic hyperglycemia, and has two major forms: type 1 DM (T1DM) and type 2 DM (T2DM). TDM1, which corresponds to 5% - 10% of the cases, is a result of β-pancreatic cell destruction with a consequent deficiency in the synthesis and secretion of insulin [<xref ref-type="bibr" rid="scirp.126424-ref1">1</xref>] . T2DM is the most common form of DM, being related to defects in the action of insulin in its target tissues [<xref ref-type="bibr" rid="scirp.126424-ref2">2</xref>] . In both types of DM, hyperglycemia can affect the structure of small nerves and large vessels, resulting in the development of diabetic micro- and macrovascular complications, respectively. Indeed, the toxic effects of hyperglycemia are highly associated with the development of retinopathy, nephropathy, neuropathy, and cardiovascular disease [<xref ref-type="bibr" rid="scirp.126424-ref3">3</xref>] .</p><p>Oxidative stress and inflammation are involved in the development of micro and macrovascular complications of DM due to an increased reactive oxygen species (ROS) availability and increased formation of advanced glycation end products (AGEs) [<xref ref-type="bibr" rid="scirp.126424-ref4">4</xref>] . AGEs are formed by the nonenzymatic glycation of plasma proteins or lipids, and glucose autoxidation. Moreover, AGEs can affect cellular function, acting through its plasma membrane-localized receptor (RAGE—Receptor for advanced glycation end products). AGE-bound RAGE mediates nuclear factor-κB (NF-κB) pathway activation that promotes the expression of proinflammatory cytokines and ROS production, leading to inflammation and endothelial dysfunction, related to increase of Intercellular Adhesion Molecule 1 (ICAM-1) [<xref ref-type="bibr" rid="scirp.126424-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.126424-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.126424-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.126424-ref8">8</xref>] .</p><p>Physical activity is defined as any bodily movement produced by skeletal muscle that results in energy expenditure. It is well known that physical activity is beneficial to DM patients due to its effects on the maintenance of blood glucose levels and prevention of several complications of DM [<xref ref-type="bibr" rid="scirp.126424-ref9">9</xref>] . The practice of moderate intensity physical activity for at least 150 min/week improves insulin sensitivity and ameliorates the lipid profile, decreasing the risk of developing T2DM [<xref ref-type="bibr" rid="scirp.126424-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.126424-ref11">11</xref>] . According to the United States Department of Health and Human Services, individuals can be classified as sedentary, low, or highly physically active. The physical activity levels can be estimated using physical activity behaviour questionnaires, being possible to access the volume of physical activity per week. Thus, individuals that have less than 150 minutes of physical activity per week are considered sedentary, while those who perform between 150 - 300 minutes per week are considered active. Finally, individuals that practice physical activity more than 300 minutes per week are classified as highly active [<xref ref-type="bibr" rid="scirp.126424-ref12">12</xref>] .</p><p>Thus, the purpose of the present study was to evaluate the influence of physical activity on oxidative stress and inflammation biomarkers in the serum of T2DM subjects.</p></sec><sec id="s2"><title>2. Methods</title><sec id="s2_1"><title>2.1. Patients</title><p>Eighty-four T2DM patients (25 men and 64 women) were enrolled in this study. Exclusion criteria were smoking, alcohol abuse, chronic viral diseases (hepatitis B and C or HIV), severe infectious disease in the last 6 months, glomerular filtration rate below 60 mL/min (calculated by the CKD-EPI formula) [<xref ref-type="bibr" rid="scirp.126424-ref13">13</xref>] . Patient's medical records were reviewed to obtain additional data for the study, such as the presence of microvascular complications and comorbidities such as systemic arterial hypertension and dyslipidemia, history of macrovascular disease and/or events (cardio or cerebrovascular events and/or non-traumatic limb amputation; previous diagnosis of coronary, carotid or peripheral arterial disease through a relevant complementary method), current medications used as well as anthropometric data. The study was approved by the Ethics Committee of the Hospital Universit&#225;rio Ant&#244;nio Pedro of Universidade Federal Fluminense, Niter&#243;i, Rio de Janeiro, Brasil (CEP-CMM/HUAP 252/11) and all participants gave written informed consent.</p></sec><sec id="s2_2"><title>2.2. Physical Activity Levels</title><p>DM patients were asked about their routine of physical activity practices at the time of the medical consultation. Participants who were unable to respond were excluded from the study. This approach was validated by Kurtze et al. (2007), presenting acceptable repeatability and being a valid measure for physical activity [<xref ref-type="bibr" rid="scirp.126424-ref12">12</xref>] . After that, the participants were divided into three groups according to their physical activity level: Group A (n = 48) composed by sedentary patients; group B (n = 11) composed by active patients (150 min, 3 times a week), and group C (n = 25) composed by highly active patients (150 - 300 min at least, 5 times a week).</p></sec><sec id="s2_3"><title>2.3. Collection and Storage of Samples</title><p>Blood samples were collected from fasting patients into tubes with or without anticoagulant (EDTA), to obtain serum or plasma, respectively. The tubes were centrifuged at 3.000&#215;g for 15 minutes to obtain serum, and 1.000&#215;g for 20 minutes to obtain plasma. After processing, serum and plasma were aliquoted in cryotubes and stored at −80˚C until further utilization.</p></sec><sec id="s2_4"><title>2.4. sRAGE Serum Levels</title><p>Serum levels of RAGE (sRAGE) (pg/mL) were measured using Enzyme Linked Immuno Sorbent Assay (ELISA) commercial kit (BioVendor, Brno, CZE), following the manufacturer’s instructions. The detection limit of the assay was 19.2 pg/mL. Intra and inter-assay coefficients of variation were 4% and 7.2%, respectively.</p></sec><sec id="s2_5"><title>2.5. Plasma SOD and GPX Activities</title><p>Plasma SOD and GPx activities were measured using commercial kits (Cayman Chemical, Michigan, USA), following the manufacturer’s instructions. SOD reduces tetrazolium salt, leading to the formation of red formazan, which was read at 440 nm in a spectrophotometer (SpectraMax M3 Multi-Mode Microplate Reader (Molecular Devices, California, USA). GPx activity was indirectly measured by the coupled reaction with glutathione reductase (GR), which oxidizes NADPH. NADPH oxidation was measured at 340 nm in a spectrophotometer (SpectraMax M3 Multi-Mode Microplate Reader (Molecular Devices, California, USA).</p><p>The detection limit of the SOD activity assay was 0.025 - 0.25 units (U)/mL SOD. Intra and inter-assay coefficients of variation were 3.2% and 3.7%, respectively. The detection limit of the GPx activity assay was 50 - 344 nmol/min/mL. Intra and inter-assay coefficients of variation were 5.7% and 7.2%, respectively. For both assays, samples were analysed at least in duplicate.</p></sec><sec id="s2_6"><title>2.6. Total Reduced Thiol Levels</title><p>Total reduced thiol groups were determined in a spectrophotometer (Hitachi U-3300) using 5,5-dithionitrobenzoic acid (DTNB). Thiols react with DTNB, cleaving the disulfide bond to give 2-nitro-5-thiobenzoate (NTB<sup>−</sup>), which ionizes to the NTB<sup>2−</sup> di-anion in water at neutral and alkaline pH. The NTB<sup>2−</sup> was quantified in a spectrophotometer at 412 nm [<xref ref-type="bibr" rid="scirp.126424-ref14">14</xref>] .</p></sec><sec id="s2_7"><title>2.7. Plasma ICAM-1 Levels</title><p>Plasma ICAM-1 levels (ng/mL) were assessed using ELISA commercial kit (Sigma-Aldrich, Missouri, USA), following the manufacturer’s instructions. The detection limit of the ICAM-1 assay was 150 pg/mL. Intra and inter-assay coefficients of variation were &lt;12% and &lt;10%, respectively.</p></sec><sec id="s2_8"><title>2.8. Statistical Analysis</title><p>Data were analysed through the statistical software SPSS 23.0 for Windows. Numerical variables were expressed as median (p25-p75). Kolmogorov-Smirnov test was performed to evaluate for normality of numerical variables. One-Way ANOVA or Kruskal-Wallis tests were used to compare numeric variables between multiple groups. Student’s t-test and Mann-Whitney test were used to compare numeric variables between the two groups. Correlations between numerical variables were evaluated using the Pearson or Spearman correlation coefficient. p values &lt; 0.05 were considered statistically significant.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Clinical and Laboratory Characteristics</title><p>Demographic, anthropometric, and laboratory characteristics of the groups are shown in <xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="table" rid="table2">Table 2</xref>. No differences were found among the groups in relation to age, DM duration, body mass index, waist-to-hip ratio, blood pressure, triglycerides (TG), HDL-c, and creatinine clearance (<xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="table" rid="table2">Table 2</xref>). HbA1c, total cholesterol (TC), and LDL-c were lower in group C when compared to groups A and B (p &lt; 0.01; 0.031 and 0.04, respectively) (<xref ref-type="table" rid="table1">Table 1</xref>).</p></sec><sec id="s3_2"><title>3.2. sRAGE, Oxidative Stress and Inflammatory Profile</title><p>No differences between groups were found in relation to sRAGE levels (<xref ref-type="table" rid="table3">Table 3</xref>). Plasma SOD activity was higher in group C when compared to group A. No significant differences were found among the groups for plasma GPx activity and total thiol levels. ICAM-1 levels were significantly higher in group B, compared to groups A and C (<xref ref-type="table" rid="table3">Table 3</xref>).</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>In the present study, diabetic subjects were categorized according to their level of physical activity. No differences between groups were found in relation to age, fasting glucose levels, and DM duration that excludes the influence of these variables in our results. Glycemic control is important to avoid DM complications,</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Demographic and anthropometric characteristics</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Group A Median (p25 - p75) n = 48</th><th align="center" valign="middle" >Group B Median (p25 - p75) n = 11</th><th align="center" valign="middle" >Group C Median (p25 - p75) n = 25</th></tr></thead><tr><td align="center" valign="middle" >Gender (M/F)</td><td align="center" valign="middle" >9/39</td><td align="center" valign="middle" >3/8</td><td align="center" valign="middle" >13/12</td></tr><tr><td align="center" valign="middle" >Age (years)</td><td align="center" valign="middle" >59 (53 - 66)</td><td align="center" valign="middle" >59 (54.5 - 61)</td><td align="center" valign="middle" >57 (51 - 64)</td></tr><tr><td align="center" valign="middle" >DM duration (months)</td><td align="center" valign="middle" >132 (54 - 222)</td><td align="center" valign="middle" >132 (90 - 156)</td><td align="center" valign="middle" >120 (57 - 177)</td></tr><tr><td align="center" valign="middle" >Body mass index (Kg/m<sup>2</sup>)</td><td align="center" valign="middle" >30.3 (27.6 - 34.5)</td><td align="center" valign="middle" >31.2 (29.7 - 32.7)</td><td align="center" valign="middle" >28.7 (26.6 - 30.8)</td></tr><tr><td align="center" valign="middle" >Waist hip ratio</td><td align="center" valign="middle" >0.9 (0.9 - 1.0)</td><td align="center" valign="middle" >0.9 (0.8– 1.0)</td><td align="center" valign="middle" >0.9 (0.9 - 1.0)</td></tr><tr><td align="center" valign="middle" >Systolic blood pressure (mmHg)</td><td align="center" valign="middle" >131 (116.5 - 143)</td><td align="center" valign="middle" >135 (124.5 - 140)</td><td align="center" valign="middle" >120 (110 - 140.7)</td></tr><tr><td align="center" valign="middle" >Diastolic blood pressure (mmHg)</td><td align="center" valign="middle" >72 (65 - 84)</td><td align="center" valign="middle" >75 (70 - 81.5)</td><td align="center" valign="middle" >69.5 (62 - 73.7)</td></tr></tbody></table></table-wrap><p>Physical activity levels: Group A: sedentary; Group B: up to 150 min/week; Group C: more than 150 min/week. Results are represented as median (p25-p75).<sup> </sup>M: male; F: female; DM: diabetes mellitus.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Laboratory parameters</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Group A Median (p25 - p75) n = 48</th><th align="center" valign="middle" >Group B Median (p25 - p75) n = 11</th><th align="center" valign="middle" >Group C Median (p25 - p75) n = 25</th><th align="center" valign="middle" >P</th></tr></thead><tr><td align="center" valign="middle" >HbA1c (%)</td><td align="center" valign="middle" >8.6 (7.2 - 10.7)</td><td align="center" valign="middle" >9.3 (8.9 - 11.5)</td><td align="center" valign="middle" >6.8<sup>a,b</sup> (6.5 - 7.8)</td><td align="center" valign="middle" >a &lt; 0.003 b &lt; 0.001</td></tr><tr><td align="center" valign="middle" >Total Cholesterol (mg/dL)</td><td align="center" valign="middle" >180 (144.7 - 206.5)</td><td align="center" valign="middle" >183 (155 - 224)</td><td align="center" valign="middle" >150<sup>c,d</sup> (135 - 170)</td><td align="center" valign="middle" >c &lt; 0.01 d &lt; 0.05</td></tr><tr><td align="center" valign="middle" >Triglycerides (mg/dL)</td><td align="center" valign="middle" >100 (70 - 158)</td><td align="center" valign="middle" >142 (66 - 151.5)</td><td align="center" valign="middle" >111 (71 - 127)</td><td align="center" valign="middle" >Ns</td></tr><tr><td align="center" valign="middle" >HDL-c (mg/dL)</td><td align="center" valign="middle" >45 (37.7 - 54.2)</td><td align="center" valign="middle" >53 (42 - 60.5)</td><td align="center" valign="middle" >42 (38 - 53)</td><td align="center" valign="middle" >Ns</td></tr><tr><td align="center" valign="middle" >LDL-c (mg/dL)</td><td align="center" valign="middle" >110 (80 - 128.5)</td><td align="center" valign="middle" >104 (79.5 - 156.5)</td><td align="center" valign="middle" >83.5<sup>c</sup> (77.7 - 100.2)</td><td align="center" valign="middle" >&lt;0.01</td></tr><tr><td align="center" valign="middle" >Creatinine clearance (mg/dL)</td><td align="center" valign="middle" >0.8 (0.7 - 0.9)</td><td align="center" valign="middle" >0.8 (0.6 - 0.8)</td><td align="center" valign="middle" >0.8 (0.7 - 1.0)</td><td align="center" valign="middle" >Ns</td></tr></tbody></table></table-wrap><p>Physical activity levels: Group A: sedentary; Group B: up to 150 min/week; Group C: more than 150 min/week. Results are represented as median (p25 - p75). <sup>a</sup>&lt;0.003<sup> </sup>versus group A; <sup>b</sup>&lt;0.001 versus group B; <sup>c</sup>&lt;0.01 versus group A; <sup>d</sup>&lt;0.05 versus group B. ns: not significant; HbA1c: glycated hemoglobin; HDL-c: high density lipoprotein; LDL-c: low density lipoprotein.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> sRAGE, Oxidative stress evaluation and inflammatory profile</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Group A Median (p25 - p75) n = 48</th><th align="center" valign="middle" >Group B Median (p25 - p75) n = 11</th><th align="center" valign="middle" >Group C Median (p25 - p75) n = 25</th><th align="center" valign="middle" >p</th></tr></thead><tr><td align="center" valign="middle" >sRAGE (pg/mL)</td><td align="center" valign="middle" >300 (263 - 501)</td><td align="center" valign="middle" >306 (284 - 373)</td><td align="center" valign="middle" >297 (288 - 386)</td><td align="center" valign="middle" >Ns</td></tr><tr><td align="center" valign="middle" >SOD (U/mL)</td><td align="center" valign="middle" >2.1 (1.9 - 3.0)</td><td align="center" valign="middle" >2.6 (2.10 - 3.8)</td><td align="center" valign="middle" >3.1<sup>a</sup> (2.3 - 3.7)</td><td align="center" valign="middle" ><sup>a</sup>p &lt; 0.01</td></tr><tr><td align="center" valign="middle" >GPx (nmol/min/mL)</td><td align="center" valign="middle" >73.8 (65.4 - 86.7)</td><td align="center" valign="middle" >75.9 (64.6 - 81.6)</td><td align="center" valign="middle" >74.6 (62.1 - 92.7)</td><td align="center" valign="middle" >Ns</td></tr><tr><td align="center" valign="middle" >ICAM-1 (ng/mL)</td><td align="center" valign="middle" >201.0 (167.8 - 226.0)</td><td align="center" valign="middle" >223.5<sup>b</sup> (198.5 - 255.4)</td><td align="center" valign="middle" >196.1<sup>c</sup> (162.3 - 221.1)</td><td align="center" valign="middle" ><sup>b</sup>p &lt; 0.04 <sup>c</sup>p &lt; 0.02</td></tr><tr><td align="center" valign="middle" >Total Thiol (mmol/mL)</td><td align="center" valign="middle" >1.11 (0.93 - 1.38)</td><td align="center" valign="middle" >1.39 (1.17 - 1.71)</td><td align="center" valign="middle" >1.16 (1.02 - 1.31)</td><td align="center" valign="middle" >Ns</td></tr></tbody></table></table-wrap><p>Physical activity levels: Group A: sedentary; Group B: up to 150 min/week; Group C: more than 150 min/week. Results are represented as median (p25-p75). <sup>a</sup>&lt;0.01 versus group A; <sup>b</sup>&lt;0.04 versus group A; <sup>c</sup>&lt;0.02 versus group B. ns: not significant. sRAGE: soluble receptor for advanced glycation end products, SOD: superoxide dismutase; GPx: glutathione peroxidase; ICAM-1: intercellular adhesion molecule 1.</p><p>and HbA1c levels higher than 7% are often associated with the development of micro and macrovascular complications [<xref ref-type="bibr" rid="scirp.126424-ref15">15</xref>] . In the present study, HbA1c levels in the highly physical active group were 6.8 %, being significantly lower than the other groups. Similar results have already been described in a meta-analysis, in which the practice of aerobic exercise in combination with resistance training was able to reduce HbA1c levels in T2DM patients when compared to their sedentary counterparts [<xref ref-type="bibr" rid="scirp.126424-ref16">16</xref>] . Moreover, Pai et al. (2016) also showed that a higher frequency of regular physical activitiy was related to a reduction of HbA1c levels in T2DM patients [<xref ref-type="bibr" rid="scirp.126424-ref17">17</xref>] . Thus, our data reinforce the idea that an increased level of physical activity is related to lower HbA1c levels in T2DM patients. Moreover, TG levels were lower in the group of highly active T2DM subjects when compared to other groups. Besides, LDL-c levels were also lower in this group in relation to the sedentary group. Our results are in line with the literature, in which higher levels of physical activity are related to beneficial effects on the lipid profile of T2DM subjects [<xref ref-type="bibr" rid="scirp.126424-ref18">18</xref>] .</p><p>In hyperglycemic conditions, there is an increase in ROS and AGEs production, which is involved in the development of DM micro-and macrovascular complications, such as CVD [<xref ref-type="bibr" rid="scirp.126424-ref19">19</xref>] . On the other hand, antioxidant defence overcomes the free radicals accumulation to avoid oxidative stress [<xref ref-type="bibr" rid="scirp.126424-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.126424-ref21">21</xref>] . High levels of physical activity are related to higher antioxidant capacity in several tissues [<xref ref-type="bibr" rid="scirp.126424-ref22">22</xref>] . In our study, plasma SOD activity was higher in group C compared to group A, but it was not different from group B. It is well established that physical activity levels are related with increases in SOD gene and protein levels, as well with its activity, thus decreasing ROS availability [<xref ref-type="bibr" rid="scirp.126424-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.126424-ref24">24</xref>] . Moreover, antioxidant enzymes can be selectively activated by physical demand according to the intensity and duration of the physical activity, depending on the amount of ROS produced by tissues and the antioxidant defence capacity of the tissue [<xref ref-type="bibr" rid="scirp.126424-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.126424-ref24">24</xref>] .</p><p>ICAM-1, which is induced by NF-κB activation, has a significant role in the pathogenesis of DM vascular complications, due to its stimulatory effects on the migration and adhesion of monocytes to the endothelium [<xref ref-type="bibr" rid="scirp.126424-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.126424-ref26">26</xref>] . We found higher levels of serum ICAM-1 in T2DM subjects who performed low levels of physical activity when compared to sedentary and highly active T2DM individuals. ICAM-1 is a well-characterized biomarker of vascular inflammation [<xref ref-type="bibr" rid="scirp.126424-ref8">8</xref>] . Physical activity has beneficial effects linked to the prevention of systemic low-grade inflammation [<xref ref-type="bibr" rid="scirp.126424-ref27">27</xref>] , and its practice is strongly recommended as a tool to prevent inflammation and CVD [<xref ref-type="bibr" rid="scirp.126424-ref28">28</xref>] . The maximal oxygen capacity seems to be inversely correlated with sICAM-1 in patients with chronic heart failure, suggesting that improved physical fitness may positively influence endothelial health [<xref ref-type="bibr" rid="scirp.126424-ref29">29</xref>] . Moreover, it was demonstrated that serum ICAM-1 levels were higher in healthy sedentary subjects in comparison to their counterparts with optimal physical activity [<xref ref-type="bibr" rid="scirp.126424-ref30">30</xref>] . Thus, more studies are necessary to explain the mechanisms related to the increase of ICAM-1 in T2DM patients that are minimally active.</p><p>The interaction of AGEs with RAGE triggers the inflammatory response and ROS generation, which are implicated in the development and progression of DM [<xref ref-type="bibr" rid="scirp.126424-ref31">31</xref>] . However, sRAGE may be protective against T2DM-associated inflammation. High levels of circulating sRAGE can avoid AGE-RAGE interaction, attenuating this response. sRAGE is reduced in individuals with impaired glucose tolerance and T2DM. On the other hand, physical exercise is able to increase circulating levels of sRAGE and reduce cardiometabolic risk factors in T2DM patients [<xref ref-type="bibr" rid="scirp.126424-ref32">32</xref>] . However, BMI and body fat percentage seem to be highly correlated with sRAGE [<xref ref-type="bibr" rid="scirp.126424-ref31">31</xref>] . In obese individuals, sRAGE is 35% lower when compared to lean subjects. In our study, sRAGE levels of T2DM patients were not affected by their physical activity level. It is important to note that BMI was not different among groups, suggesting that changes in body composition are required for the beneficial effect of physical activity on sRAGE levels, at least in individuals with T2DM.</p><p>We showed that physical activity could improve the quality of life of individuals with T2D significantly. The effect of physical activity on social relations needs more time. We suggest evaluating the effect of physical activity on social relations with a longer time follow-up in future studies. In conclusion, the volume and frequency of physical activity play an important role in the control of metabolic parameters, as well as redox and inflammatory biomarkers in T2DM patients. Low levels of physical activity were not efficient to decrease oxidative stress response and proinflammatory markers. Moreover, our data suggest that changes in body composition are important to observe the beneficial effects of physical activity on sRAGE levels in T2DM individuals.</p></sec><sec id="s5"><title>Author Contributions</title><p>A.M.T., J.H.S and C.O.B wrote the manuscript and researched data.</p><p>L.M.P and C.N contributed to the discussion, R.S.F contributed to the discussion and reviewed the manuscript.</p><p>G.F.T. and L.C.C.W. researched the data and reviewed/edited the manuscript.</p><p>A.M.T is the guarantor of this work and, as such, has full access to all data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</p></sec><sec id="s6"><title>Acknowledgements</title><p>We thank the ever-attentive biologists, Solange Lopes and Maria Alice Cardozo, and their laboratory team of the HUAP-UFF for their invaluable assistance throughout the study.</p></sec><sec id="s7"><title>Financial Support</title><p>This work was supported by grants from Coordena&#231;&#227;o de Aperfei&#231;oamento de Pessoal de N&#237;vel Superior (CAPES) (A, M.T. and C.O.B) and Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado do Rio de Janeiro (FAPERJ) E-26/111.905/2011 (to G.F.T.) and E-26/202.532/2015 (to JH).</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s9"><title>Cite this paper</title><p>Tavares, A.M., Matta, L., da Silva, J.H., Bensusan, C.O., Nascimento, C., Taboada, G.F., Fortunato, R.S. and Cardoso-Weide, L.C. (2023) Physical Activity Alters Superoxide Dismutase Activity and Intercellular Adhesion Molecule 1 Levels in Diabetes Mellitus Type 2 Patients. Journal of Biosciences and Medicines, 11, 140-150. https://doi.org/10.4236/jbm.2023.117012</p></sec><sec id="s10"><title>Abbreviations</title><p>Diabetes mellitus (DM);</p><p>Diabetes mellitus type 2 (T2DM);</p><p>Superoxide dismutase (SOD);</p><p>Glutathione Peroxidase (GPx);</p><p>Glutathione (GSH);</p><p>Soluble receptor of advanced glycation end product (sRAGE);</p><p>Intercellular adhesion molecule 1 (ICAM-1).</p></sec><sec id="s11"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.126424-ref1"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Robillard</surname><given-names> R. </given-names></name>,<etal>et al</etal>. (<year>1959</year>)<article-title>The Pathogenesis of Diabetes Mellitus</article-title><source> L’Union Médicale du Canada</source><volume> 88</volume>,<fpage> 1190</fpage>-<lpage>1201</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.126424-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Moctezuma-Velazquez, C., Gómez-Sámano, M.á., Cajas-Sánchez, M.B., et al. (2017) High Dietary Magnesium Intake Is Significantly and Independently Associated with Higher Insulin Sensitivity in a Mexican-Mestizo Population: A Brief Cross-Sectional Report. Revista de Investigación Clínica, 69, 40-46. https://doi.org/10.24875/RIC.17002086</mixed-citation></ref><ref id="scirp.126424-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Asmat, U., Abad, K. and Ismail, K. (2016) Diabetes Mellitus and Oxidative Stress—A Concise Review. Saudi Pharmaceutical Journal, 24, 547-553. https://doi.org/10.1016/j.jsps.2015.03.013</mixed-citation></ref><ref id="scirp.126424-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Dobi, A., Bravo, S.B., Veeren, B., et al. (2019) Advanced Glycation End-Products Disrupt Human Endothelial Cells Redox Homeostasis: New Insights into Reactive Oxygen Species Production. Free Radical Research, 53, 150-169. https://doi.org/10.1080/10715762.2018.1529866</mixed-citation></ref><ref id="scirp.126424-ref5"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tessier</surname><given-names> F.J. </given-names></name>,<etal>et al</etal>. (<year>2010</year>)<article-title>La réaction de Maillard dans le corps humain. Découvertes majeures et facteurs qui affectent la glycation</article-title><source> Pathologie Biologie</source><volume> 58</volume>,<fpage> 214</fpage>-<lpage>219</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.126424-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Brownlee, M. (2001) Biochemistry and Molecular Cell Biology of Diabetic Complications. Nature, 414, 813-820. https://doi.org/10.1038/414813a</mixed-citation></ref><ref id="scirp.126424-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Yonekura, H., Yamamoto, Y., Sakurai, S., Watanabe, T. and Yamamoto, H. (2005) Roles of the Receptor for Advanced Glycation Endproducts in Diabetes-Induced Vascular Injury. Journal of Pharmacological Sciences, 97, 305-311. https://doi.org/10.1254/jphs.CPJ04005X</mixed-citation></ref><ref id="scirp.126424-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Tavares, A.M., Silva, J.H., de Oliveira Bensusan, C. and Ferreira, A.C.F. (2019) Altered Superoxide Dismutase-1 Activity and Intercellular Adhesion Molecule 1 (ICAM-1) Levels in Patients with Type 2 Diabetes Mellitus. PLOS ONE, 14, e0216256. https://doi.org/10.1371/journal.pone.0216256</mixed-citation></ref><ref id="scirp.126424-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Ogurtsova, K., da Rocha Fernandes, J.D., Huang, Y., et al. (2017) IDF Diabetes Atlas: Global Estimates for the Prevalence of Diabetes for 2015 and 2040. Diabetes Research and Clinical Practice, 128, 40-50. https://doi.org/10.1016/j.diabres.2017.03.024</mixed-citation></ref><ref id="scirp.126424-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Jessen, N., An, D., Lihn, A.S., et al. (2011) Exercise Increases TBC1D1 Phosphorylation in Human Skeletal Muscle. American Journal of Physiology-Endocrinology and Metabolism, 301, E164-E171. https://doi.org/10.1152/ajpendo.00042.2011</mixed-citation></ref><ref id="scirp.126424-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Vind, B.F., Pehmoller, C., Treebak, J.T., et al. (2011) Impaired Insulin-Induced Site-Specific Phosphorylation of TBC1 Domain Family, Member 4 (TBC1D4) in Skeletal Muscle of Type 2 Diabetes Patients Is Restored by Endurance Exercise-Training. Diabetologia, 54, 157-167. https://doi.org/10.1007/s00125-010-1924-4</mixed-citation></ref><ref id="scirp.126424-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Kurtze, N., Rangul, V., Hustvedt, B.E. and Flanders, W.D. (2007) Reliability and Validity of Self-Reported Physical Activity in the Nord-Trondelag Health Study (HUNT 2). European Journal of Epidemiology, 22, 379-387. https://doi.org/10.1007/s10654-007-9110-9</mixed-citation></ref><ref id="scirp.126424-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Kalousová, M., Hodková, M., Kazderová, M., et al. (2006) Soluble Receptor for Advanced Glycation End Products in Patients with Decreased Renal Function. American Journal of Kidney Diseases, 47, 406-411. https://doi.org/10.1053/j.ajkd.2005.12.028</mixed-citation></ref><ref id="scirp.126424-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Ellman, G.L. (1959) Tissue Sulfhydryl Groups. American Journal of Kidney Diseases, 82, 70-77. https://doi.org/10.1016/0003-9861(59)90090-6</mixed-citation></ref><ref id="scirp.126424-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">American Diabetes Association (2019) 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes 2019. Diabetes Care, 42, S124-S138. https://doi.org/10.2337/dc19-S011</mixed-citation></ref><ref id="scirp.126424-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Umpierre, D., Ribeiro, P.A.B., Kramer, C.K., et al. (2011) Physical Activity Advice Only or Structured Exercise Training and Association with HbA1c Levels in Type 2 Diabetes: A Systematic Review and Meta-Analysis. JAMA: The Journal of the American Medical Association, 305, 1790-1799. https://doi.org/10.1001/jama.2011.576</mixed-citation></ref><ref id="scirp.126424-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Pai, L.W., Li, T.C., Hwu, Y.J., Chang, S.C., Chen, L.L. and Chang, P.Y. (2016) The Effectiveness of Regular Leisure-Time Physical Activities on Long-Term Glycemic Control in People with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Diabetes Research and Clinical Practice, 113, 77-85. https://doi.org/10.1016/j.diabres.2016.01.011</mixed-citation></ref><ref id="scirp.126424-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Baskerville, R., Ricci-Cabello, I., Roberts, N. and Farmer, A. (2017) Impact of Accelerometer and Pedometer Use on Physical Activity and Glycaemic Control in People with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Diabetic Medicine, 34, 612-620. https://doi.org/10.1111/dme.13331</mixed-citation></ref><ref id="scirp.126424-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Lee, J., Yun, J.S. and Ko, S.H. (2022) Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus. Nutrients, 14, 3086.https://doi.org/10.3390/nu14153086</mixed-citation></ref><ref id="scirp.126424-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Martins Gregório, B., De Souza, D.B., de Morais Nascimento, F.A., Matta, L. and Fernandes-Santos, C. (2016) The Potential Role of Antioxidants in Metabolic Syndrome. Current Pharmaceutical Design, 22, 859-869. https://doi.org/10.2174/1381612822666151209152352</mixed-citation></ref><ref id="scirp.126424-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Andriantsitohaina, R., Duluc, L., GariIa-RodrIguez, J.C., et al. (2012) Systems Biology of Antioxidants. Clinical Science, 123, 173-192. https://doi.org/10.1042/CS20110643</mixed-citation></ref><ref id="scirp.126424-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Gawron-Skarbek, A., Chrzczanowicz, J., Kostka, J., et al. (2015) Physical Activity, Aerobic Capacity, and Total Antioxidant Capacity in Healthy Men and in Men with Coronary Heart Disease. Oxidative Medicine and Cellular Longevity, 2015, Article ID: 197307. https://doi.org/10.1155/2015/197307</mixed-citation></ref><ref id="scirp.126424-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Gleeson, M., Bishop, N.C., Stensel, D.J., Lindley, M.R., Mastana, S.S. and Nimmo, M.A. (2011) The Anti-Inflammatory Effects of Exercise: Mechanisms and Implications for the Prevention and Treatment of Disease. Nature Reviews Immunology, 11, 607-615. https://doi.org/10.1038/nri3041</mixed-citation></ref><ref id="scirp.126424-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Pinho, R.A., Andrades, M.E., Oliveira, M.R., et al. (2006) Imbalance in SOD/CAT Activities in Rat Skeletal Muscles Submitted to Treadmill Training Exercise. Cell Biology International, 30, 848-853. https://doi.org/10.1016/j.cellbi.2006.03.011</mixed-citation></ref><ref id="scirp.126424-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Clausen, P., Jacobsen, P., Rossing, K., Jensen, J.S., Parving, H.H. and Feldt-Rasmussen, B. (2000) Plasma Concentrations of VCAM-1 and ICAM-1 Are Elevated in Patients with Type 1 Diabetes Mellitus with Microalbuminuria and Overt Nephropathy. Diabetic Medicine, 17, 644-649. https://doi.org/10.1046/j.1464-5491.2000.00347.x</mixed-citation></ref><ref id="scirp.126424-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Witkowska, A.M. (2005) Soluble ICAM-1: A Marker of Vascular Inflammation and Lifestyle. Cytokine, 31, 127-134. https://doi.org/10.1016/j.cyto.2005.04.007</mixed-citation></ref><ref id="scirp.126424-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Hotamisligil, G.S. (2017) Inflammation, Metaflammation and Immunometabolic Disorders. Nature, 542, 177-185. https://doi.org/10.1038/nature21363</mixed-citation></ref><ref id="scirp.126424-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Pedersen, B.K. (2017) Anti-Inflammatory Effects of Exercise: Role in Diabetes and Cardiovascular Disease. European Journal of Clinical Investigation, 47, 600-611. https://doi.org/10.1111/eci.12781</mixed-citation></ref><ref id="scirp.126424-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Tonjes, A., Scholz, M., Fasshauer, M., et al. (2007) Beneficial Effects of a 4-Week Exercise Program on Plasma Concentrations of Adhesion Molecules. Diabetes Care, 30, e1. https://doi.org/10.2337/dc06-1760</mixed-citation></ref><ref id="scirp.126424-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Bacelova, M.G., Nikolova, J.G., Deneva, T. and Nikolov, P.F. (2018) Arterial Stiffness, Plasma Atherogenic Index and Soluble Cell Adhesion Molecules in Healthy Young Adults with Reduced Physical Activity. Archives of Physiology and Biochemistry, 124, 357-360. https://doi.org/10.1080/13813455.2017.1408661</mixed-citation></ref><ref id="scirp.126424-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Miranda, E.R., Somal, V.S., Mey, J.T., et al. (2017) Circulating Soluble RAGE Isoforms Are Attenuated in Obese, Impaired-Glucose-Tolerant Individuals and Are Associated with the Development of Type 2 Diabetes. American Journal of Physiology-Endocrinology and Metabolism, 313, E631-E640. https://doi.org/10.1152/ajpendo.00146.2017</mixed-citation></ref><ref id="scirp.126424-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Choi, K.M., Han, K.A., et al. (2012) Effects of Exercise on sRAGE Levels and Cardiometabolic Risk Factors in Patients with Type 2 Diabetes: A Randomized Controlled Trial. The Journal of Clinical Endocrinology &amp; Metabolism, 97, 3751-3758. https://doi.org/10.1210/jc.2012-1951</mixed-citation></ref></ref-list></back></article>